Adrián Sánchez-Fdez

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Sofía Del Carmen, Mar Abad, Elena Arconada-Luque, Jaime Jiménez-Suárez, Luis Miguel Chinchilla-Tábora, Mª José Ruíz-Hidalgo, Ricardo Sánchez-Prieto, Atanasio Pandiella, Azucena Esparís-Ogando
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications. Experimental & molecular medicine (2023)
Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Juan Carlos Montero, Sofía Del Carmen, Mar Abad, Sara García-Alonso, Somshuvra Bhattacharya, Kristin Calar, Pilar de la Puente, Alberto Ocaña, Atanasio Pandiella, Azucena Esparís-Ogando
The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib. Clinical and translational medicine 13 (4) (2023)
Elena Arconada-Luque, Jaime Jiménez-Suarez, Raquel Pascual-Serra, Syong Hyun Nam-Cha, Teresa Moline, Francisco J Cimas, Germán Fliquete, Marta Ortega-Muelas, Olga Roche, Diego M Fernandez-Aroca, Raúl Muñoz Velasco, Natalia García-Flores, Cristina Garnés-García, Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Víctor Javier Sánchez-Arévalo Lobo, Javier Hernández-Losa, Borja Belandia, Atanasio Pandiella, Azucena Esparís-Ogando, Santiago Ramón Y Cajal, Luis Del Peso, Ricardo Sanchez-Prieto, María José Ruiz-Hidalgo
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology. Cancers 14 (14) (2022)

Adrián Sánchez-Fdez.css-eqlu8i{font-size:small;padding-left:4px;}